intro

agenda

sessions

speakers

credits

sponsors

exhibitors

registration

hotel

home

 



Sessions

Monday, September 26
9:15 - 9:45 a.m.
Plenary Session

Survey on AMC Security Practice Status
This session provides the results of a survey of security practices taken from a representative sample of AMCs. The survey allows for ranking AMCs and for describing the level of HIPAA Security Rule compliance. The analysis will aid you in addressing several questions including: How do you stack up? Is anybody compliant today? Where are AMCs having trouble with compliance?

Session Objectives:

  • Describe the current state of compliance with the HIPAA Security Rule among AMCs.
  • List three areas in which most AMCs are having problems and three key success factors in reaching compliance.

Monday, September 26
10:15 - 11:30 a.m.
Clinical Research Track

Managing High Profile Incidents and Breaches
What is an incident? A breach? Who is involved? What is different with the high profile incidents and breaches? At long last it has happened – a research MD has her laptop stolen in the airport and her identifiable HIV research data are lost with it. Now what? How do you handle the technical, legal, regulatory and public relations issues associated with a high profile security incident/breach? Do you come clean and go public or hold back to better manage the potential fallout? Should you change security practices? Does any of this involve the ISO looking for another line of work? Hear the panel relate their real and anticipated experiences. Come with your own suggestions.

Session Objectives:

  • Describe the dimensions of a major privacy incident and at least one technique for addressing each.
  • Describe how to prepare for such an incident.

Monday, September 26
10:15 - 11:30 a.m.
Future Track

Future Uses of Encryption
Hardly a week passes that we don’t hear about an incident in which a database at a major institution (including many AMCs) with sensitive health information is hijacked or lost. Even with this high reporting rate, most observers think that only a fraction of such incidents ever become public. What can/will be done to protect this data? Will encryption of databases be commonplace? Will separating the identifying info from the content help protect confidentiality? Will spreading data across multiple devices help both availability and confidentiality? Will laws emerge to require such protections?

Session Objectives:

  • Describe scenarios in which data encryption reduces risks to confidentiality.
  • Explain how at least one specific AMC is using encryption of data at rest to better manage security risk.

Monday, September 26
1:00 - 2:15 p.m.
Clinical Research Track

Risk Assessments in Research
All AMCs manage research risk. This panel session will discuss such risks as Intellectual Property thefts, ePHI loss, internal intrusion, data continuity, and accounting for disclosure inside smaller databases.

Session Objectives:

  • Identify key institutional information-related risks to research and how AMCs are measuring the existence and extent of such risks.
  • List three areas in which many AMCs experience externally information-related risks and how they are planning to manage them.

Monday, September 26
1:00 - 2:15 p.m.
Future Track

Evolving Security & Privacy Laws & Regulations
The last few years have seen an explosion of laws and regulations that related to privacy and security of sensitive data (e.g., GLBA, CLIA, JCAHO, SOX, HIPAA and FDA, Part 11). Taken together, these federal laws and a growing number of state laws are an attempt to assure that the growing dependence that our institutions have on information systems does not lead to abuses or institutional (especially AMC) collapse. But, how do the requirements work in concert with each other within and between AMCs? And, where are the next generation of legal/regulatory requirements likely to take us? How can we leverage the experiences of other countries that are addressing these issues?

Session Objectives:

  • List the major national laws and describe whether/how they apply to AMCs.
  • List three trends in public policy that may impact how AMCs manage information over the next 3-5 years.

Monday, September 26
1:00 - 2:15 p.m.
Security Track

Changing Your Corporate Information Security Culture: The Battle for Hearts and Minds
Most AMCs list the need for “culture change” as an important element in getting their security programs to work. What are the elements of culture change? How can AMCs be led by their ISO through these changes? How fast can these changes be expected to take place? Hear the panel talk about their successes and frustrations in this area. Offer your own sage advice.

Session Objectives:

  • Describe elements of culture change needed in the typical AMC.
  • Describe two or more techniques for effecting culture change in the typical AMC.

Monday, September 26
2:45 - 4:00 p.m.
Clinical Research Track

Don't Just Say "No" to Multi-site Research in this HIPAA Environment
The Privacy Rule allows research to be done under multiple mechanisms: authorizations and waiver or alteration of authorization are the primary ones. What are the AMCs doing to facilitate multi-site research? What happens to the data when the rule is interpreted differently by separate institutions? Is the effort worth it? Separate vs. combined authorizations and consent for research? Consistent language? Who reviews? The FDA seems to have stuck its head in the sand, but most AMCs subject all research to the Common Rule; are AMCs starting to opt out of the joint compliance to reduce the administrative burden?

Databases for future, unspecified research (at Pharma) are a challenge for IRBs under the Common Rule and ignored by the FDA. How are AMCs addressing them? This panel will represent several of the different models that are used by AMCs to accomplish research and remain compliant with institutional IRB approval and monitoring guidelines.

Session Objectives:

  • Identify the relative advantages of combined vs. separate consents and authorizations.
  • Identify two of the challenges of multi-site research.

Monday, September 26
2:45 - 4:00 p.m.
Future Track

State Laws & Regulations: Current Trends and Their Implications to AMCs
HIPAA’s Privacy and Security Rules are superseded by more stringent (i.e. more protective) state law. When the HIPAA Privacy and Security Rules went into effect, approximately half of the states had some related laws that were more stringent. States like California and Washington have been active in increasing their privacy and security protections since then. Where is this matrix of more stringent state law going? What does it mean to institutions doing business across state lines? Which states are leading the charge and who is following?

Session Objectives:

  • List three ways in which states are employing laws that are more stringent than HIPAA.
  • Describe two specific state privacy-related laws that are being considered for replication by other states and what effect these laws are expected to have.

Monday, September 26
2:45 - 4:00 p.m.
Security Track

Seeking Your Contingency Plan: Are You Hot, Cold or Warm?
Many AMCs are motivated to support extensive contingency plans both because of HIPAA’s requirement to have a contingency plan and because of their growing concern about the loss of availability of key systems. But these are expensive functions to support to reduce the risk of very low frequency events. How do you balance cost and benefit? How much testing is enough? How do you choose between onsite backup, hot sites, cold sites, and warm sites? Is business continuity insurance a part of the plan? Hear the panel share their experience with addressing these questions and respond to your questions.

Session Objectives:

  • Describe the major factors involved in choosing which type of recovery facility to use.
  • Discuss whether other AMCs have chosen to have significant recovery capabilities.

Monday, September 26
4:30 - 5:45 p.m.
Clinical Research Track

Beyond HIPAA Regulation Inside the Research Quadrant
What about other federal laws and their impact on AMC behaviors in research (e.g., NIH and FDA)? What are the expectations for compliance with other mandates to protect patient data? How do these regulations overlap with the Security rule?

Session Objectives:

  • Describe other laws to protect patient data.
  • Discuss how these other laws overlap with the HIPAA Security Rule.

Monday, September 26
4:30 - 5:45 p.m.
Future Track

Identity and Access Management
Having closer and more centralized management of identities and user access rights can be a challenge for many AMCs. There is increasing pressure to better secure health information and to ensure that only the people who have a need and right to the information can access it. This session will address the many challenges of managing identities and implementing more granular access controls in an AMC setting. This includes the types of strategies, solutions and practical implications that AMCs are contemplating over the next 3-5 years.

Session Objectives:

  • Describe the challenges associated with effectively managing identities and access privileges.
  • Identify strategies and the various types of solutions to more effectively manage identities and access rights.

Monday, September 26
4:30 - 5:45 p.m.
Security Track

Logging and Review: HIPAA Style
The HIPAA Security Rule requirements to log security-related system activity and to review the logs for potential breaches leaves many AMCs wondering how to operationalize these ideas. Hear the panel talk about how their AMCs are dealing wit this issue. Bring your own concerns and answers to share.

Session Objectives:

  • Describe who other AMCs are interpreting the logging/review requirement.
  • Describe at least two approaches to assuring that the reviews are being carried out.

Tuesday, September 27
9:15 - 10:15 a.m.
Plenary Session

Future AMC Privacy & Security Issues
When you consider the 3+ year time frame, what scenarios will give rise to new challenges and opportunities in the area of information privacy and security for AMCs? What can they do to set the stage now for these scenarios and monitor their development? Do implanted ID chips have a future? What would happen with massive use of health records on smart cards? These and other scenarios will be explored.

Session Objectives:

  • Describe at least three likely scenarios that will require a large change in information security and privacy programs.
  • Describe at least three ways in which you can prepare for these scenarios at your AMC.

Tuesday, September 27
12:30 - 1:45 p.m.
Clinical Research Track

Evaluating the Effectiveness of Your Privacy and Security Programs
How are your privacy and security programs performing? What is the compliance level with your various privacy and security policies? What changes have been reasonably effective? How have your privacy and security programs changed the overall culture? The panelists will discuss these topics as seen from their respective AMCs.

Session Objectives:

  • Describe three elements of an effective audit program.
  • Discuss two new places to "look under the covers" to discover privacy weaknesses.

Tuesday, September 27
12:30 - 1:45 p.m.
Future Track

The Future of the Common Rule & its Effect on Privacy & Security
The Common Rule was originally designed to support a common set of requirements in the area of privacy for medical research done with federal support. It was touted as a major improvement over the 10+ rule sets in place before. Now HIPAA has added its effects, the problems of dealing with multiple IRBs when engaged in the increasingly popular multi-site trials has emerged, and other nations are writing laws to support privacy. Where is this complex of requirements for protecting privacy when conducting medical research going over the next few years?

Session Objectives:

  • List three problems that medical research will face over the next 3-5 years in managing privacy.
  • List three potential approaches to managing these problems.

Tuesday, September 27
2:15 - 3:30 p.m.
Clinical Research Track

The Impact of HIPAA Privacy on the Recruitment Efforts for Clinical Trials
Now that the Privacy Rule is in place, what has happened with the recruitment for clinical trials efforts? Are the restrictions for candidate contact so tight that recruitment is hampered? Listen to leading institutions who have varying experiences discuss the impact of the HIPAA Privacy Rule on their recruitment efforts.

Session Objectives:

  • Describe how wide or how narrowly focused this problem is.
  • Learn what three leading AMCs are doing creatively to enhance recruitment with compliance under the Rule.

Tuesday, September 27
2:15 - 3:30 p.m.
Future Track

International Security & Privacy: Effects from Outsourced Services, International Medicine & Research
Along with other industries, healthcare has become a more global enterprise over the last few years. Single medical research projects go on across national boundaries. Outsourced services such as transcription are undertaken to save money but raise privacy concerns. If the next deadly virus should arrive on the afternoon flight, how should the public’s health and the privacy issues be balanced? The panel will explore these topics and how their AMCs are addressing them.

Session Objectives:

  • List three ways in which AMC privacy and security management is being affected by the globalization of the healthcare industry.
  • Discuss trends related to privacy, security and global health expected to affect AMCs over the next 3-5 years.

Tuesday, September 27
2:15 - 3:30 p.m.
Security Track

Emailing ePHI
Most AMCs are ambivalent about how to manage the emailing of ePHI. While most see that the privacy/security of traditional email is low, the attractiveness of using traditional email is high. What to do? Should you require encryption? How can you make secure messaging easy enough to win over clinicians? Should you use a web site and SSL to support messaging? Will having your patients accept the privacy risk if they want to use email work? The panel members relate the considerations and outcomes of the debate at their AMCs on this topic.

Session Objectives:

  • Describe the major techniques for providing secure email.
  • Describe rejected alternatives from at least two AMCs.

Tuesday, September 27
4:00 - 5:15 p.m.
Clinical Research Track

Information Risk Mitigation in the Conduct of Research
Once risks are identified, they must be managed in order to maintain institutional integrity and HIPAA compliance. Regardless of the AMC’s designation model, risks exist in the creation, use, storage or transmission of data. This panel will discuss mitigation plans used to manage such occurrences through federal mandates, encryption standards, vendor agreements, sanctions, etc.

Session Objectives:

  • Identify five research risks and the associated means of mitigating them as well as the sanctions and penalties for failure to comply.
  • Describe at least one problem associated with conflicting state and federal laws.

Tuesday, September 27
4:00 - 5:15 p.m.
Future Track

RHIOs: New Security and Privacy Issues
The introduction of information systems at more health care sites and functions is being pursued enthusiastically at conferences, by government, and at AMCs. Further, the typical vision calls for widespread sharing of individual health data to improve safety, effectiveness and efficiency. But doing so introduces problems and opportunities in privacy and security that are not part of our current world. How can the problems be engaged and the opportunities exploited to assure that the confidentiality, availability and integrity of data are maintained or improved? How do patients perceive this move to greater connectivity and information sharing?

Session Objectives:

  • List four problems and opportunities associated with the widespread use of interconnected health information systems.
  • Identify three key early efforts to solve these problems and/or exploit the opportunities.

Tuesday, September 27
4:00 - 5:15 p.m.
Security Track

Risky Business: Analyzing Your AMC's Security Risk
Volumes have been written about doing security risk analysis. Yet carrying out this HIPAA-required process seems to leave many AMC security leaders concerned and perplexed. Do you need an overall analysis for your AMC, one for each system, or something in between? Which risks are “reasonably anticipated”? The panel offers their expert advice on how to carry out the risk analysis process in an effective and efficient way.

Session Objectives:

  • Describe how at least two AMCs manage their risk analysis process.
  • Discuss how to determine whether a proposed risk is reasonably anticipated or not.

Wednesday, September 28
9:00 - 10:15 a.m.
Clinical Research Track

Tying Up Loose Ends in Research
There are a plethora of disclosures subject to accounting. We get the obvious ones – required by law, communicable diseases, tumor registries, law enforcement. But what about some of the others – CMS submissions through your ORYX vendor, research disclosures without individual authorization, disclosures allowed under the transition provisions. Hear your panelists talk about how their AMCs have addressed these and others documentation and logging processes. What is happening in those organizations that are creating their own research software? What are the issues of access logging and change control that they face?

Session Objectives:

  • Describe two disclosures they may not be accounting for.
  • Discuss how other AMCs are implementing their disclosure tracking and what has changed in the practical management since the rule went into effect now that there is something to measure.

Wednesday, September 28
9:00 - 10:15 a.m.
Future and Security Track

Authentication: Traditional & Innovative Techniques
What kind of password policies are AMCs using now? Have group accounts really gone away? Are any AMCs using biometrics, smart cards or proximity detectors to aid in authentication? Is single sign-on in use anywhere? The panel discusses what their AMCs are doing with today’s tools for authentication. Bring your own hot question or brilliant solution to authentication to this session.

Session Objectives:

  • Describe how AMCs are assuring that passwords are robust.
  • Describe what uses AMCs are making of smart cards and biometrics to authenticate users.